Using a similar methodology to the Illicit Drug Reporting System (IDRS), the EDRS monitors the price, purity and availability of ‘ecstasy’ (3,4- methylenedioxymethamphetamine; MDMA) and other related drugs such as methamphetamine, cocaine, gamma-hydroxybutyrate (GHB), d-lysergic acid diethylamide (LSD) and ketamine. It also examines trends in the use and harms of these drugs. It utilises data from surveys with people who use ecstasy and/or stimulants regularly.
Resources
Date commenced
07 Feb 2018
Resource type
Drug trends jurisdictional reports
Author(s)
Julia Uporova
- Overview
- News
- Our team
- References
